- US12611405utility2026Agent That Increases the Expression of the Bcl2-associated Agonist of Cell Death for the Treatment of Cancer0 cites
- US12497663utility2025Method of Monitoring Treatment0 cites
- US12324805utility2025Cancer Treatment0 cites
- US12144807utility2024Priming of Cancer Cells with Low Dose Naltrexone0 cites
- US12029737utility2024Autoimmune Therapy0 cites